Skip to main content
. 2020 Jul 1;7(3):112–117. doi: 10.5152/eurjrheum.2020.19132

Table 3.

Pharmacologic treatment in patients with pSS.

Medications, % C3 complement levels C4 complement levels


Normal (n=85) Low (n=9) p Normal (n=81) Low (n=13) p
Pilocarpine 8.4 11.1 0.576 7.5 16.7 0.279
Cevimiline 44.7 33.3 0.727 44.4 38.5 0.686
Cyclosporine (ophthalmic) 27.1 33.3 0.704 29.6 15.4 0.504
NSAIDs 48.2 55.6 0.737 50.6 38.5 0.416
Prednisone 31.8 55.6 0.265 30.9 53.9 0.123
Hydroxychloroquine 89.4 77.8 0.283 87.7 92.3 0.999
Methotrexate 7.1 12.5 0.479 6.2 16.7 0.222
Azathioprine 4.7 11.1 0.402 4.9 7.7 0.533
Rituximab 2.4 22.2 0.045 2.5 15.4 0.091

NSAIDs: Nonsteroidal anti-inflammatory drugs; pSS: Primary Sjögren’s syndrome.